Capecitabine plus docetaxel combination therapy
ثبت نشده
چکیده
Health technology Two treatment options for patients with anthracycline-pretreated metastatic breast carcinoma were examined. The options were capecitabine (CAP) plus docetaxel (DOC) combination therapy and DOC alone. In the former (CAP+DOC), oral capecitabine (1,250 mg/m2 twice daily was given on days 1 14, followed by a 7-day rest period, with docetaxel (75 mg/m2) administered as a 1-hour intravenous (i.v.) infusion on the first day of each 3-week cycle. In the latter, DOC (100 mg/m2) was administered as a 1-hour i.v. infusion on the first day of each 3-week cycle.
منابع مشابه
Nonanthracycline containing docetaxel-based combinations in metastatic breast cancer.
Many active nonanthracycline-containing regimens are emerging from clinical trials and may offer the option of treating metastatic breast cancer without resorting to doxorubicin or analogues. When used first-line in metastatic breast cancer, both cisplatin and carboplatin are active agents and hence candidates for combination therapy. In a dose-finding study in patients with no prior chemothera...
متن کاملPopulation-based pharmacoeconomic model for adopting capecitabine/docetaxel combination treatment for anthracycline-pretreated metastatic breast cancer.
PURPOSE To model the cost-effectiveness of adopting capecitabine/docetaxel combination therapy in place of single-agent taxane therapy for women in the province of Ontario, Canada, receiving treatment for anthracycline-pretreated metastatic breast cancer. METHODS Clinical effectiveness and economic data were combined in a population model, from the perspective of a universal health care syste...
متن کاملA Phase II Study of Sequential Capecitabine Plus Oxaliplatin Followed by Docetaxel Plus Capecitabine in Patients With Unresectable Gastric Adenocarcinoma
Fluorouracil and platinum are considered the standard treatment options for advanced gastric cancer. Docetaxel is also an effective agent and it shows no cross-resistance with fluorouracil and platinum. The combination treatment of docetaxel with fluorouracil and platinum has been explored, but it demonstrated intolerable toxicities. An alternative approach in the first-line treatment of gastri...
متن کاملFirst-line chemotherapy with docetaxel plus capecitabine followed by capecitabine or hormone maintenance therapy for the treatment of metastatic breast cancer patients
The primary aim of the present study was to evaluate whether maintenance therapy with capecitabine or hormone replacement therapy (HRT) results in improved progression-free survival (PFS) in metastatic breast cancer (MBC) patients who had previously achieved disease control with first-line docetaxel plus capecitabine (TX) chemotherapy. Seventy-nine metastatic breast cancer patients treated betw...
متن کاملThe role of capecitabine in first-line treatment for patients with metastatic breast cancer.
Capecitabine is an important drug in the therapeutic armamentarium for metastatic breast cancer. A comprehensive worldwide clinical trial program involving >10,000 patients with locally advanced and metastatic breast cancer has provided evidence for the current treatment strategies. On the basis of data demonstrating consistent activity across several trials in patients with heavily pretreated ...
متن کامل